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As part of a study to determine the effects of water fil-
tration on the incidence of community-acquired gastroen-
teritis in Melbourne, Australia, we examined fecal samples
from patients with gastroenteritis and asymptomatic per-
sons for diarrheagenic strains of Escherichia coli. Atypical
strains of enteropathogenic E. coli (EPEC) were the most
frequently identified pathogens of all bacterial, viral, and
parasitic agents in patients with gastroenteritis. Moreover,
atypical EPEC were more common in patients with gas-
troenteritis (89 [12.8%] of 696) than in asymptomatic per-
sons (11 [2.3%] of 489, p < 0.0001). Twenty-two random
isolates of atypical EPEC that were characterized further
showed marked heterogeneity in terms of serotype, genet-
ic subtype, and carriage of virulence-associated determi-
nants. Apart from the surface protein, intimin, no virulence
determinant or phenotype was uniformly present in atypical
EPEC strains. This study shows that atypical EPEC are an
important cause of gastroenteritis in Melbourne.
S
trains of Escherichia coli that cause diarrhea are clas-
sified into pathotypes (or virotypes) according to their
specific virulence determinants (1). These virulence deter-
minants give each pathotype the capacity to cause a clini-
cal syndrome with distinctive epidemiologic and
pathologic characteristics. For example, enterohemorrhag-
ic E. coli (EHEC) may cause hemorrhagic colitis and the
hemolytic uremic syndrome because of their production of
Shiga toxins, whereas enteroaggregative E. coli (EAEC)
are associated with persistent diarrhea in children in less-
developed countries (1). Enteropathogenic E. coli (EPEC)
share several key virulence determinants with the most
common varieties of EHEC, but lack Shiga toxins, and
cause nonspecific diarrhea in infants in less-developed
countries (2,3). EPEC also differ from EHEC in that they
typically carry an EPEC adherence factor plasmid (EAF).
This plasmid encodes both bundle-forming pili (Bfp) that
promote bacterial adherence to mammalian cells and are
required for virulence (4) and a transcriptional activator,
known as Per, that upregulates genes, such as eae, within a
pathogenicity island termed the locus for enterocyte
effacement (LEE) (5). LEE is required to produce attach-
ing-effacing lesions, which are characteristic of EPEC-
induced pathology. A subset of EPEC, known as atypical
EPEC, does not carry EAF and hence does not produce
Bfp (3). The role of EPEC in disease is uncertain. 
The principal reservoir of EHEC is food animals, in
particular, cattle, which harbor these bacteria in the distal
intestinal tract and from which bacteria can spread to
humans through fecally contaminated food or water (1).
Although the other pathotypes of diarrheagenic E. coli
generally do not originate in animals, they may also spread
to humans through food or water contaminated with excre-
ment. Recently, we conducted a study to determine if the
water supply of Melbourne, Australia’s second largest city
with  >3 million inhabitants, is a source of intestinal
pathogens that are responsible for community-acquired
gastroenteritis. Among the pathogens that were sought
were diarrheagenic E. coli, including atypical EPEC,
which emerged as the predominant cause of gastroenteritis
in this community. 
Materials and Methods
The design of the Water Quality Study (WQS), which
was conducted from September 1997 to February 1999,
has been reported previously (6). Briefly, 600 Melbourne
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enrolled in the study. Each family was allocated at random
to receive a real or sham water treatment unit, which was
installed in the kitchen of their home and supplied water
through a separate faucet. Family members, comprising
2,811 persons, were followed for 15 months (68 weeks).
Each participating household had a nominated member
who completed a weekly questionnaire regarding the pres-
ence, duration, and severity of gastrointestinal symptoms.
The primary endpoint of the study was highly credible gas-
troenteritis, which was defined as exhibiting any of the fol-
lowing symptoms in a 24-hour period: two or more loose
stools, two or more episodes of vomiting, one loose stool
together with abdominal pain or nausea or vomiting, or
one episode of vomiting with abdominal pain or nausea.
Cases of highly credible gastroenteritis were deemed to be
distinct if the participant was symptom-free for at least 6
days. 
Sample Collection and Processing
Participants in the study were asked to collect fecal
specimens during episodes of gastroenteritis. Atotal of 795
specimens collected during 2,669 reported episodes of gas-
troenteritis were examined for rotavirus, adenovirus,
Norwalk-like viruses, Giardia spp., and Cryptosporidium
spp. and were cultured for Salmonella spp., Shigella spp.,
Campylobacter spp., Vibrio spp., Yersinia spp., Aeromonas
spp.,  Plesiomonas spp., and Clostridium difficile, as
described previously (6,7). Baseline frequencies of these
pathogens in the study population were determined during
the 4-month period, May through August 1997, immedi-
ately preceding the WQS. Frequencies were examined by
investigating 1,091 fecal specimens from a convenience
sample of participants. Participants who provided a base-
line specimen were similar to those who did not provide a
specimen in age, sex, and family background.
Examination of Feces for E. coli
Sufficient funds were available to investigate 1,250
samples for diarrheagenic E. coli. Of these samples, 500
were randomly selected from 1,091 fecal samples obtained
from healthy persons in the baseline study, and 750 sam-
ples were randomly selected from the 795 samples
obtained from participants with highly credible gastroen-
teritis in the WQS. 
Bacteria were isolated from fecal samples by direct
plating on MacConkey agar (Oxoid Ltd., Basingstoke,
UK). After overnight incubation at 37°C, a sterile cotton
swab was used to transfer the entire growth from each
plate into Luria broth containing 30% (vol/vol) glycerol,
which was then frozen at –70°C until required.
Diarrheagenic strains of E. coli were identified by poly-
merase chain reaction (PCR) and confirmed by Southern
hybridization. Template DNAfor use in PCR was prepared
from bacteria grown in 2.5 mL of MacConkey broth that
contained a loopful of stored frozen culture and was incu-
bated with shaking at 37°C overnight. One milliliter of this
culture was centrifuged to pellet the bacteria, the super-
natant was removed, and then the pellet was washed in 1
mL of phosphate buffer, resuspended in 200 µL sterile dis-
tilled water, and heated for 10 min at 100°C. Samples were
then placed on ice for 5 min and recentrifuged at 16,000 x
g. Aliquots of the supernatant were pipetted into sterile
tubes and stored for <1 week at –20°C before use.
PCR amplifications were performed in a Gene Amp
PCR System 9700 thermal cycler (Applied Biosystems,
Foster City, CA) with AmpliTaq Gold polymerase
(Applied Biosystems) and the primers listed in Table 1 in
a reaction volume of 20 µL (for single reactions) or 50 µL
(for multiplex PCR). The genes identified by these primers
and their association with each pathotype of diarrheagenic
E. coli are listed in Tables 1 and 2. PCR for the lacZ gene,
which is found in almost all wild-type strains of E. coli,
was included as a control to ensure that negative PCR
assays were not a result of the absence of viable bacteria in
the sample or the presence of inhibitors in the reaction
mixture. Samples that were negative in the PCR for lacZ
(3.6% of all those examined) were excluded from further
analysis. At the conclusion of the PCR, 10 µL of the reac-
tion mixture underwent electrophoresis on 2.5% 96-well
format agarose gels (Electro-fast, ABgene, Epsom, UK).
Gels were stained with ethidium bromide, visualized on a
UV transilluminator, and photographed. A portion of the
PCR product was retained for Southern blotting, which
was performed by using capillary transfer of separated
DNA fragments onto positively charged nylon membranes
(Roche Diagnostics Ltd., Lewes, UK). Digoxigenin-
labeled DNA probes were prepared by PCR (Roche
Diagnostics) from the control strains (Table 2) by using the
PCR primers listed in Table 1. The integrity of the probes
was determined by nucleotide sequencing. Probes were
hybridized overnight under conditions of high stringency
at 65°C and detected by using chemiluminescence as rec-
ommended by the manufacturer. Probe-positive bacteria
were assigned to a pathotype according the criteria in
Table 2. Equivocal or ambiguous assays were repeated,
and if results were still unclear, these specimens were
excluded from further analysis.
Characterization of Isolates
Twenty-two EPEC isolates (11 from healthy persons
and 11 from persons with diarrhea) were isolated in pure
culture. Representative colonies of each were then
serotyped with hyperimmune rabbit antisera (16). These
strains were also subjected to PCR with the primers and
conditions listed in Table 3 to determine intimin subtype
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ciated genes. The same 22 strains were also examined for
their ability to adhere to and invade HEp-2 epithelial
cells.
Bacterial Adhesion and Invasion of HEp-2 Cells
The Center for Vaccine Development (University of
Maryland, Baltimore, MD) method was used to determine
the pattern of bacterial adherence to HEp-2 epithelial cells
(12). Bacterial strains were designated nonadherent if <10
of 200 HEp-2 cells had five or more bacteria attached. The
fluorescent actin staining (FAS) assay, which correlates
with the ability of E. coli to produce attaching-effacing
lesions in the intestine, was performed by using a 6-h incu-
bation period (22). At the completion of the assay, cells
were examined by fluorescence and phase-contrast
microscopy to confirm that fluorescent areas corresponded
to attached bacteria. Bacterial strains that gave equivocal
or negative results in the FAS assay were investigated for
DNA corresponding to regions of the LEE, other than eae,
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DNAprobes and hybridization conditions described previ-
ously (23). Quantitative assessment of the ability of E. coli
to invade HEp-2 cells was performed with the gentamicin-
protection assay (24). Results were expressed as the num-
ber of bacteria recovered from HEp-2 cells after treatment
with gentamicin as a percentage of the total number of
cell-associated bacteria (24).
Statistical analysis was performed with InStat version
3.0 (GraphPad Software Inc., San Diego, CA). Ap value <
0.05 was considered significant.
Results 
Association of E. coli Pathotypes with Gastroenteritis
After excluding samples for which patient data were
incomplete (12 samples), which were negative by PCR for
lacZ (45 samples), or which gave equivocal results in the
PCR or DNA hybridization assays (8 samples), 1,185
(94.8%) samples of the original 1,250 were available for
analysis: 696 from patients with gastroenteritis and 489
from healthy persons. The results of the assays are sum-
marized in Table 4. Enterotoxigenic (ETEC) and enteroin-
vasive (EIEC) strains of E. coli and Bfp-positive EPEC
were identified in <0.5% of healthy persons or patients
with gastroenteritis. EHEC were present in 4 (0.6%) of 696
of samples from persons with gastroenteritis and in no
healthy persons, but the difference between the two groups
was not significant (p = 0.15, Fisher exact test, 2-tailed). In
contrast, both EAEC and atypical (Bfp-negative) EPEC
were identified in >5% of patients, and the difference
between the symptomatic and baseline groups was signifi-
cant for each of these pathotypes (Table 4). Analysis of the
data pertaining to patients in whom EAEC and atypical
EPEC were identified showed that atypical EPEC were
more frequent in younger persons; patients with atypical
EPEC were a median age of 3.4 years, compared with 7.4
years for the symptomatic group overall (p < 0.0001;
Mann-Whitney test, 2-tailed). Of all atypical EPEC in
study participants with gastroenteritis, 75 (84%) were
identified in children <10 years old, compared with 14
(16%) in patients >10 years (relative rate [RR] 3.4, 95%
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age of patients infected with EAEC was 7.3 years.
Examining the seasonal occurrence of gastroenteritis
from all causes showed that gastroenteritis was more com-
mon in the warmer months; 65.7% of cases occurred in the
6 months from October through March (Figure 1).
Infections with EAEC and atypical EPEC reflected this
distribution with 80% and 65.5% of infections with these
bacteria, respectively, occurring during the same period.
The high incidence of EAEC in February and March may
have been caused by small family outbreaks; 9 of 25 cases
during this period originated in three households. 
In view of the seasonal variation in the occurrence of
EAEC and atypical EPEC, we reanalyzed the data and
compared the symptomatic and baseline groups, because
the EPEC were examined only during the 4-month period
from May through August, 1997. This analysis showed
that the occurrence of EAEC in persons with gastroenteri-
tis (6 [3.8%] of 157) and in asymptomatic persons (15
[3.1%] of 489) was essentially the same during May
through August of 1998 and 1997, respectively (RR 1.2,
95% CI 0.5–3.0). In contrast, atypical EPEC were more
frequent in the gastroenteritis group during the same peri-
od; 19 (12.1%) of 157 of symptomatic patients were posi-
tive for these bacteria, compared with 11 (2.3%) of 489 for
the asymptomatic group (RR 5.7, 95% CI 3.1–10.5, p <
0.0001; Fisher exact test, 2-tailed). The frequency of atyp-
ical EPEC in symptomatic patients from households with
real and sham water treatment units was similar (42
[12.3%] of 341 and 47 [13.2%] of 355, respectively).
Characterization of EPEC Isolates
Pure cultures of PCR- and probe-positive atypical
EPEC were obtained from 22 randomly selected samples
that were positive in the original PCR. These isolates were
characterized further to establish their identity as EPEC
and to determine if they belonged to a limited number of
clones. All strains were identified as atypical EPEC in that
they were negative for bfpA, stx1, stx2, aggA, and aggR.
Determination of O:H serotype and intimin subtype
revealed that although strains from each sample were the
same, those obtained from different persons were highly
heterogeneous, and no two isolates belonged to the same
serotype and intimin subtype (Table 5). Only three isolates
were of serotypes (O55:H7 and O126:H6 [two isolates])
that commonly include atypical EPEC. In addition, one
isolate, W145, was serotype O55:H6, which includes typi-
cal EPEC strains (2). Eight isolates were O-serogroups that
were classified as nontypeable because they did not react
with any of the available O-typing sera (O1–O181), and
one isolate had an H antigen that did not react with any of
the available H-typing sera (H1–H56) and was classified
as nontypeable.
Atypical EPEC strains were also heterogeneous in their
carriage of putative accessory virulence determinants
(Table 5). Although all bacteria were, by definition, nega-
tive for bfpA, nearly all were also negative for efa1 and
lpfD, the genes for factors that have been implicated as
adhesins of some attaching-effacing strains of E. coli
(19,25). Only two strains were positive for astA, which has
also been suggested to contribute to the virulence of atyp-
ical EPEC (26).
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Figure 1. Seasonal incidence in gastroenteritis in the Melbourne
Water Quality Study, 1998. Solid black bars indicate all cases of gas-
troenteritis as a percentage of the total, with the number of cases
indicated above each bar. The frequencies of enteroaggregative
Escherichia coli (EAEC) and enteropathogenic E. coli (EPEC) are
expressed as a percentage of all cases examined each month.Adhesion to HEp-2 Cells. 
Typical EPEC adhere to HEp-2 cells in a distinctive
pattern termed localized adherence, which requires the
presence of Bfp (5). The 22 atypical EPEC strains isolated
in this study showed variable patterns of adherence to
HEp-2 cells, including aggregative adherence (7 strains)
and a pattern previously termed localized-like adherence
(1 strain) (27). Ten strains showed an indeterminate pattern
of adherence, with small numbers of bacteria distributed
apparently at random on the cell surface (Figure 2), and 4
strains were classified as nonadherent. The frequency of
strains displaying each pattern of adherence was similar
among isolates from patients with gastroenteritis and
healthy persons. All atypical EPEC strains that adhered to
HEp-2 cells, regardless of their pattern of adhesion, were
positive in the FAS assay (Figure 3), which indicates that
the LEE in these bacteria is functional. All nonadherent
strains hybridized with DNA probes were derived from
different regions of LEE, which suggests that they carry
the entire pathogenicity island. We did not attempt to
determine whether LEE was functional in these bacteria.
Previous reports of atypical EPEC have suggested that
invasion of epithelial cells may contribute to the virulence
of these bacteria (28). In this study, however, only one
strain, W1056 (O55:H7), was able to invade HEp-2 cells to
a noticeable extent (Table 5). 
Discussion
The role of EPEC as a cause of diarrhea in children,
particularly in developing countries, is now well estab-
lished (2,3). The proven virulence determinants of EPEC
include genes within the LEE, notably intimin (the outer
membrane protein product of the eae gene), and Bfp,
which is encoded by EAF (5). The key role of EAF in pro-
moting the virulence of EPEC was established by Levine
et al. (12), who showed that an EAF-negative derivative
strain of EPEC, E2348/69, is markedly less virulent for
adult volunteers than the wild-type strain. The same study
showed that an atypical EPEC strain, E128012, which
intrinsically lacks EAF, is also virulent in volunteers. This
observation established that certain EPEC strains do not
require EAF to cause disease. These intrinsically EAF-
negative strains were originally called Class II EPEC (2,3)
but are now more generally referred to as atypical EPEC.
They are characterized by the presence of LEE and the
absence of factors encoded by EAF, in particular, Bfp. In
this way, atypical EPEC resemble EHEC, which are able to
cause diarrhea despite their lack of Bfp. Indeed, persuasive
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serotype O157:H7, evolved from an atypical EPEC strain
of serotype O55:H7 (29). 
The aims of the WQS were to investigate the effect of
household water treatment units on the incidence of gas-
troenteritis in Melbourne and to identify causative agents
of gastroenteritis in the study population. The microbio-
logic investigations showed that the detection rate of
EAEC (6.5%) and atypical EPEC (12.3%) in patients with
diarrhea was greater than that of Campylobacter spp. (3%),
Salmonella spp. (1.1%), adenovirus (1.1%), rotavirus
(1.4%),  Cryptosporidium spp. (1.6%), and Giardia spp.
(2.5%) and was matched only by that of noroviruses
(11.4%) (6,7,30).
Together, atypical EPEC and EAEC accounted for
19.3% of all cases; 21% of cases were attributable to all
other bacterial, viral, and parasitic causes combined.
However, the frequency of EAEC in patients with gas-
troenteritis and that in the baseline group without diarrhea
was the same when matched for the time of year when the
sample of feces was collected. In contrast, atypical EPEC
was isolated significantly more often from patients with
gastroenteritis than from those without symptoms, regard-
less of when the sample was collected. A subset of 22 ran-
domly selected atypical EPEC strains was examined and
found to be highly heterogeneous, which indicates that the
high frequency of atypical EPEC in the study population
was not the result of one or more outbreaks attributable to
a small number of strains. 
Despite the persuasive evidence of a volunteer study
and reports of outbreaks of diarrhea with atypical EPEC
(12,26,31), the role of atypical EPEC in disease is contro-
versial. Originally, atypical EPEC were grouped with
EPEC but were then segregated because they lack EAF.
Justification for this division stemmed from the observa-
tion that EAF-bearing EPEC far outnumber atypical EPEC
as the cause of infantile diarrhea in less-developed coun-
tries and of diarrhea outbreaks in general (3). In recent
reports, however, from countries as diverse as Iran,
Poland, South Africa, and the United Kingdom, atypical
EPEC strains have outnumbered typical strains as a cause
of gastroenteritis (32–35). Atypical EPEC were also more
frequent than typical strains in aboriginal children hospi-
talized for diarrhea in the Northern Territory of Australia
(36). These findings were reflected in the present study: 89
(94%) of eae-bearing strains identified in patients with
gastroenteritis were atypical EPEC.
As for EPEC in general, atypical EPEC were originally
incriminated as intestinal pathogens by virtue of their epi-
demiologic association with cases of diarrhea (2).
Subsequently, these strains, which had been identified by
serotype alone, were shown to be EPEC sensu stricto (37).
Although atypical EPEC generally are serotypes which
differ from EAF-positive EPEC (and other pathotypes of
diarrheagenic E. coli), the 12 O-serogroups recognized by
the World Health Organization as EPEC (i.e., serogroups
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Figure 2. Patterns of adherence of atypical
enteropathogenic Escherichia coli strains (arrows)
to HEp-2 epithelial cells. A) aggregative adherence,
B) localized-like adherence, and C) indeterminate
adherence. Magnification x1,000.
Figure 3. Fluorescent actin staining (FAS) assay for attaching-
effacing capacity of atypical enteropathogenic Escherichia coli
(EPEC) strains with different patterns of adherence to HEp-2 cells.
Fluorescent micrographs of HEp-2 cells (A and B) incubated with
strains of atypical EPEC showing localized-like and aggregative
adherence, respectively, and then reacted with fluorescein-
labelled phalloidin. Note the foci of intense fluorescence (arrows)
associated with adherent bacteria, which were also visualized by
phase contrast microscopy of the same microscope fields (C and
D). Magnification x1,000.O26, O55, O86, O111, O114, O119, O125, O126, O127,
O128, O142, and O158) include both typical and atypical
varieties (3). Some of the atypical EPEC strains within
these serogroups carry accessory virulence-associated
determinants such as the EHEC hemolysin (commonly
found in serotypes O26:H11 and O111ac:H8). Some
strains also carry astA, the gene for enteroaggregative
heat-stable enterotoxin, EAST1, which is frequently found
in serotypes O55:H7, O119:H2, and O128:H2 (3). Atypical
EPEC strains of non-EPEC serogroups generally do not
express these factors. In the present study, none of the 89
atypical strains was positive for ehxA, which is required
for the production of EHEC hemolysin, and although two
strains (both serogroup O55) tested positive for astA, both
carried the previously described mutations in this gene,
which would preclude the synthesis of biologically active
enterotoxin (38). 
Unlike EAF-bearing strains of EPEC, which show
localized adherence to HEp-2 cells, atypical EPEC show
different patterns of adherence. Although some investiga-
tors have reported localized-like adherence as a predomi-
nant adherence pattern of atypical EPEC (28,39), only 1 of
22 strains investigated here displayed this phenotype. The
low frequency of localized-like adherence in this study
may reflect differences in serotype distribution, as local-
ized-like adherence seems to be most prevalent in atypical
EPEC strains in EPEC serogroups, such as O26, O111, and
O119 (28), which were infrequently found in this study.
Ten of the 22 strains examined exhibited an adherence pat-
tern that was distinct from localized, aggregative, or dif-
fuse adherence (3) and was termed indeterminate
adherence (Figure 1). This pattern may have been termed
diffuse adherence by other investigators, which would
account for the relatively high frequency of diffusely
adherent atypical EPEC in some reports and their absence
from this study. Seven of 22 strains displayed aggregative
adherence despite their lack of known sequences associat-
ed with the production of fimbriae of EAEC. 
The virulence of atypical EPEC despite their lack of
Bfp, which typical EPEC require to cause severe disease,
suggests that these bacteria carry an adhesin analogous to
Bfp that augments their ability to colonize the intestine.
Previous studies, however, have shown only a low fre-
quency of known E. coli adhesins, including aggregative
adherence fimbriae, P fimbriae, S fimbriae, PAP pili, and
afimbrial adhesins in atypical EPEC strains (40). We
extended these findings to show that atypical EPEC are
also mostly negative for Efa1 and long polar fimbriae
(encoded by lpfD), which contribute to the adhesive capac-
ities of some attaching-effacing strains of E. coli (19,25). 
Although atypical EPEC may carry an adhesin equivalent
to Bfp, which remains to be discovered, these bacteria may
use any known E. coli adhesins to bind to the intestine.
This suggestion is supported by the marked heterogeneity
of atypical EPEC in terms of adhesion pattern and the
observation that adhesins other than Bfp can restore cell-
binding capacity to EAF-cured strains of typical EPEC
(41).
In conclusion, atypical EPEC were the most commonly
identified pathogens in a study of community-acquired
diarrhea in Melbourne. Infections with atypical EPEC
occurred throughout the year and were significantly more
common in children. Characterization of a sample of atyp-
ical EPEC isolates revealed that these bacteria were anti-
genically heterogeneous and generally did not belong to
O-serogroups associated with EPEC. Further studies are
needed to determine the frequency of these bacteria in
other communities, their reservoir, mode of spread, and
mechanisms of virulence. 
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